ICUI - ICU Medical, Inc. Stock Analysis

Stock Taper

SCREENER COMPARE ANY 2 STOCKS

ICUI

ICU MEDICAL, INC.

NASDAQ

$175.10

▲ UP 0.00% (0.00)

KEY STATISTICS

Market Cap$4.38 B

52w High$192.85

52w Low$112.50

Dividend Yield—

Frequency—

P/E21.86

Volume162.21K

Shares Out.24.99M

COMPANY

LEADERSHIP

CHIEF EXECUTIVE

Vivek Jain

COMPENSATION 2026

Salary$775,000

Stock Awards$4,500,023

Incentive Plan Pay$1,162,500

All Other Comp.$14,519

Total$6,452,042

ABOUT

SECTOR

Healthcare

WENT PUBLIC

March 31, 1992

METHOD OF GOING PUBLIC

IPO

FULL TIME EMPLOYEES

13,000

PRICE TARGET

Target High$200.00

Target Low$163.00

Target Median$187.00

Target Consensus$186.40

UPCOMING EARNINGS

DateNov 5, 2026

DayThursday

Rev. Est.$552.13M

NOV

THU

SPLIT RECORD

DATE	TYPE	RATIO
2002-03-18	Forward	3:2
1993-04-01	Forward	3:2

PRICE

$175.10 ▲ UP 0.00% (+$0.00)

OVERLAYS

About ICU Medical, Inc.

https://www.icumed.com ↗

ICU Medical, Inc. develops and sells medical devices and solutions for infusion therapy and critical care worldwide, including products for catheter access, IV therapy, and hemodynamic monitoring.

INDUSTRY

Medical - Instruments & Supplies

A PRODUCT ICU MEDICAL, INC. IS KNOWN FOR

Plum Duo Precision IV Pump

The Plum Duo, an FDA-cleared dual-channel precision IV pump with a touchscreen and LifeShield integration, advances ICU Medical’s infusion therapy by enhancing accuracy and safety.

COMPETITORS

COMPETITOR

Revenue by Products

PRODUCT	Q3-2025	Q4-2025	Q1-2026	Q2-2026
Equipment revenue	$51.56M	$0 ▼	$42.68M ▲	$76.62M ▲
Software revenue	$4.29M	$24.61M ▲	$10.02M ▼	$18.61M ▲
Other deferred revenue	$646K	$141K ▼	$830K ▲	$1.32M ▲
Government Grant Revenue	-$1.54M	$503K ▲	-$505K ▼	-$934K ▼

Revenue by Geography

REGION	Q3-2025	Q4-2025	Q1-2026	Q2-2026
UNITED STATES	$307.13M	$325.31M ▲	$315.5M ▼	$349.9M ▲
EMEA	$115.09M	$101.84M ▼	$104.68M ▲	$95.07M ▼
Asia Pacific	$57.48M	$57.61M ▲	$58.3M ▲	$55.63M ▼
Other Foreign Countries	$57.29M	$55.94M ▼	$51.75M ▼	$51.08M ▼